Package leaflet: Information for the patient UK …

Package leaflet: Information for the user Clexane …

1 Package leaflet: Information for the user. Clexane® Syringes 2,000 IU (20 mg)/0.2 ml solution for injection in pre-filled syringes . Clexane® Syringes 4,000 IU (40 mg)/0.4 ml solution for injection in pre-filled syringes

  Clexane

small pharma code may appear on the front / back …

Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the blister and carton after EXP.

  Pharma

PACKAGE LEAFLET: INFORMATION FOR THE USER

1.3.1. Package Leaflet 1 PACKAGE LEAFLET: INFORMATION FOR THE USER CALCEOS 500mg/400IU CHEWABLE TABLETS …

  Information, User, Leaflet, Packages, Package leaflet, Information for the user

PACKAGE LEAFLET: INFORMATION FOR THE USER

1.3.1 Package Leaflet 1 Package leaflet: Information for the patient Laxido Orange, powder for oral solution. Read all of this leaflet carefully before you start taking this medicine because it contains

  Information, User, Leaflet, Packages, Package leaflet, Information for the user, Information for the

Package leaflet: Information for the user - Medicines

Page 1 of 8 v019_0 Due to regulatory changes, the content of the following Patient Information Leaflet may vary from the one found in your medicine pack.

Package leaflet: Information for the user …

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. • Keep this leaflet.

PFIZER Package leaflet: Information for the patient …

Page 1 of 20 PFIZER Package leaflet: Information for the patient Depo-Provera® 150 mg/ml Sterile Suspension for Injection Medroxyprogesterone acetate Please read all of this leaflet carefully before you start using this medicine because it

  Information, Leaflet, Packages, Pfizer, Information for the, Depo, Pfizer package leaflet

SAYANA PRESS 104 mg/0.65 ml suspension for …

Page 1 of 15 Package leaflet: Information for the user SAYANA PRESS® 104 mg/0.65 ml suspension for injection medroxyprogesterone acetate Single-dose container ...

  Single, Dose, Injection, Acetate, Suspension, Medroxyprogesterone, Suspension for injection medroxyprogesterone acetate single dose

PACKAGE LEAFLET: INFORMATION FOR THE USER …

PACKAGE LEAFLET: INFORMATION FOR THE USER Bisoprolol 2.5 mg Film-coated Tablet Bisoprolol 5 mg Film-coated Tablet Bisoprolol 10 mg Film-coated Tablet

Patient Information Leaflet - Medicines

Page 2 of 10 Patient Information Leaflet Salazopyrin® EN-tabs 500 mg enteric-coated tablets sulfasalazine In this leaflet: 1. What Salazopyrin EN …

  Information, Patients, Leaflet, Patient information leaflet

RIAMET 20 MG/120 MG DISPERSIBLE TABLETS …

MHRA PAR – Riamet 20 mg/120 mg dispersible tablets (PL 00101/0957) - 1 - RIAMET 20 MG/120 MG DISPERSIBLE TABLETS (Artemether and lumefantrine) PL 00101/0957 . UKPAR . TABLE OF CONTENTS

  Tablets, 120 mg dispersible tablets, Dispersible, Artemether and lumefantrine, Artemether, Lumefantrine

Sasol Germany GmbHSasol Germany GmbH - Our …

Features of Sasol dispersible aluminas The unique product characteristics of Sasol dispersible aluminas can lead to many advantages for use in different

  Germany, Gmbh, Sasol, Sasol germany gmbhsasol germany gmbh, Gmbhsasol, Dispersible

Madopar (levodopa) Data Sheet (DS) - Medsafe

MADOPAR 160202 1 Data Sheet MADOPAR® Levodopa + benserazide Capsules 62.5, 125 and 250; dispersible tablet 62.5; HBS modified-release capsule 125

  Levodopa, Dispersible

2016.05.20 Fluox DS - Medsafe Home Page

Page 1 of 11 NEW ZEALAND DATA SHEET FLUOX Fluoxetine hydrochloride Capsules 20 mg Fluoxetine hydrochloride Dispersible Tablets 20 mg Presentation

  Dispersible, Fluox ds, Fluox

REVISION OF MONOGRAPH ON TABLETS - World …

Document QAS/09.324/Final page 6 Disintegration test Uncoated tablets, except soluble tablets, dispersible tablets, effervescent tablets and tablets for use in the mouth comply with 5.3 Disintegration test for tablets and

  World, Monographs, Tablets, Revisions, Dispersible, Revision of monograph on tablets

Dispersible Aspirin 75mg Tablets BP PL 17907 0155-6

MHRA PAR – Dispersible Aspirin 75mg Tablets BP (PL 17907/0155-6) - 1 - DISPERSIBLE ASPIRIN 75MG TABLETS BP PL 17907/0155-6 …

  Tablets, Aspirin, Dispersible, Dispersible aspirin 75mg tablets bp, 75mg

FAO SPECIFICATIONS AND EVALUATIONS FOR …

fao specifications and evaluations for imidacloprid page 2 of 53 part one specifications imidacloprid page imidacloprid information 3 imidacloprid technical material (may 2013) 4

  Specification, Evaluation, Fao specifications and evaluations for

Dosing instructions for the use of currently available ...

September 2009 Dosing instructions for the use of currently available fixed-dose combination TB medicines for children Document 1 Detailed information

  Dose, Combination, Currently, Fixed, Available, Use of currently available fixed dose combination